News

DIY tirzepatide, internet detective work and insurance appeals: The lengths 3 people are going to for weight loss drugs. Story by Natalie Rahhal • 1w.
Demand for glucagon-like peptide-1 weight-loss drugs — such as Ozempic, Zepbound and Wegovy — coupled with limited insurance coverage has fueled a risky but growing “gray” market for purchasing active ...
Tirzepatide was first approved for use in the US in May 2022, when it received an indication for adult patients with type 2 diabetes. 1 Indications for chronic weight management and sleep apnea ...
The active ingredient in the drug, tirzepatide, has already been approved for the treatment of Type 2 diabetes under the name Mounjaro since May 2022. But the FDA's new approval means adults who ...
In this second half of a recent interview on trends in tirzepatide use, Jaime Almandoz, MD, MBA, calls for scalable, team-based care models to support the growing use of obesity medications like ...
DIY tirzepatide, internet detective work and insurance appeals: The lengths 3 people are going to for weight loss drugs "Not being on it is not an option." Natalie Rahhal, Reporter.